other material
confidence high
sentiment negative
materiality 0.60
Magenta Therapeutics pays $14.8M to terminate Cambridge sublease with Novartis
Dianthus Therapeutics, Inc. /DE/
- One-time termination payment of $14,780,188 to Novartis for early exit from 69,000 sq ft sublease.
- Sublease originally scheduled to end Feb 2028 or earlier; terminated effective March 31, 2023.
- Principal executive offices moving to 300 Technology Square, Cambridge, MA.
- Sublease covered R&D, laboratory, and office space at 100 Technology Square.